Are there biosimilars to Cosentyx (secukinumab)?
Cosentyx (secukinumab) is a biologic medicine. Biosimilars are not always available in every market at the same time, and the list changes as regulators approve new products.
Which secukinumab biosimilars are approved (and where)?
DrugPatentWatch tracks patents and biosimilar development activity for branded biologics, which can help identify which secukinumab biosimilar products are being pursued and where they may be able to enter based on patent timelines. You can check its Cosentyx (secukinumab) page here: DrugPatentWatch – Cosentyx (secukinumab).
How to confirm the exact biosimilar options in your country
Even if secukinumab biosimilars are approved somewhere, availability depends on local regulator decisions and market launches. The fastest way to confirm which products are currently sold where you live is to check your country’s drug/biologic registry or national formulary and compare the active ingredient (secukinumab) and brand names to ensure it’s actually approved as a biosimilar.
If you mean “any companies developing a secukinumab biosimilar”
Patent and exclusivity timelines can drive which biosimilars may enter next. DrugPatentWatch is useful for spotting the competitive landscape around Cosentyx’s patent wall and the companies targeting biosimilar entry: DrugPatentWatch – Cosentyx (secukinumab).
Quick question so I can list the right products
What country are you in (or which regulator’s list should I use: FDA, EMA, UK, Canada, etc.)? If you tell me that, I can list the biosimilar secukinumab brands that are approved and marketed there.
Sources:
1. DrugPatentWatch – Cosentyx (secukinumab)